Hindman Andrew A.
SVP, CHIEF FINANCIAL OFFICER at TBPH; Chief Business Officer at ACORDA THERAPEUTICS INC
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Nov 18, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- TBPHTheravance Biopharma, Inc.SVP, CHIEF FINANCIAL OFFICER
- ACORDA THERAPEUTICS INCChief Business Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- TBPH65,000 shares
- ACORDA THERAPEUTICS INC62,413 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ACORDA THERAPEUTICS INCPlan not statedDec 1, 2015 2015
Sold 442 shares at $38.26 ($17k)
Hindman Andrew A., Chief Business Dev. Officer
Sold 0.8% of holdings ($2.1M position)54,530 shares leftFiling
- 2 Form 4 sale ACORDA THERAPEUTICS INCPlan not statedMay 13, 2016 +164 days
Sold 4,860 shares at $26.11 ($127k)
Hindman Andrew A., Chief Business Dev. Officer
Sold 8.9% of holdings ($1.4M position)49,670 shares leftFiling
- 3 Form 4 sale ACORDA THERAPEUTICS INCPlan not statedDec 1, 2016 +202 days
Sold 443 shares at $20.72 ($9k)
Hindman Andrew A., Chief Business Dev. Officer
Sold 0.9% of holdings ($1M position)49,227 shares left0.1x usual sizeFiling
- 4 Form 4 sale ACORDA THERAPEUTICS INCUnusualMay 15, 2017 +165 days
Sold 7,704 shares at $15.75 ($121k)
Hindman Andrew A., Chief Business Dev. Officer
Sold 14.3% of holdings ($848k position)46,123 shares left17.4x usual sizeFiling
- 5 Form 4 sale ACORDA THERAPEUTICS INCPlan not statedDec 1, 2017 +200 days
Sold 817 shares at $20.54 ($17k)
Hindman Andrew A., Chief Business Dev. Officer
Sold 1.8% of holdings ($947k position)45,306 shares left0.2x usual sizeFiling
- 6 Form 4 sale ACORDA THERAPEUTICS INCUnusualMay 25, 2018 +175 days
Sold 42,615 shares at $24.26 ($1M)
Hindman Andrew A., Chief Business Officer
Sold 90.4% of holdings ($1.1M position)4,503 shares left52.2x usual sizeFiling
- 7 Form 4 sale ACORDA THERAPEUTICS INCPlan not statedDec 3, 2018 +192 days
Sold 753 shares at $20.56 ($15k)
Hindman Andrew A., Chief Business Officer
Sold 12.7% of holdings ($122k position)5,171 shares left0.1x usual sizeFiling
- 8 Form 4 sale TBPHPlan not statedNov 18, 2022 +1446 days
Sold 65,000 shares at $11.02 ($716k)
Hindman Andrew A., SVP, CHIEF FINANCIAL OFFICER
Sold 13.7% of holdings ($5.2M position)409,771 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Nov 22, 2022 | TBPH | SVP, CHIEF FINANCIAL OFFICER | Form 4 sale | 65,000 | $716k | 13.7% | Plan not stated | SEC |
| Dec 3, 2018 | Dec 6, 2018 | ACORDA THERAPEUTICS INC | Chief Business Officer | Form 4 sale | 753 | $15k | 12.7% | Plan not stated | SEC |
| May 25, 2018 | May 30, 2018 | ACORDA THERAPEUTICS INC | Chief Business Officer | Form 4 sale | 42,615 | $1M | 90.4% | Unusual | SEC |
| Dec 1, 2017 | Dec 5, 2017 | ACORDA THERAPEUTICS INC | Chief Business Dev. Officer | Form 4 sale | 817 | $17k | 1.8% | Plan not stated | SEC |
| May 15, 2017 | May 17, 2017 | ACORDA THERAPEUTICS INC | Chief Business Dev. Officer | Form 4 sale | 7,704 | $121k | 14.3% | Unusual | SEC |
| Dec 1, 2016 | Dec 5, 2016 | ACORDA THERAPEUTICS INC | Chief Business Dev. Officer | Form 4 sale | 443 | $9k | 0.9% | Plan not stated | SEC |
| May 13, 2016 | May 16, 2016 | ACORDA THERAPEUTICS INC | Chief Business Dev. Officer | Form 4 sale | 4,860 | $127k | 8.9% | Plan not stated | SEC |
| Dec 1, 2015 | Dec 3, 2015 | ACORDA THERAPEUTICS INC | Chief Business Dev. Officer | Form 4 sale | 442 | $17k | 0.8% | Plan not stated | SEC |
| May 15, 2015 | May 15, 2015 | ACORDA THERAPEUTICS INC | Chief Business Dev. Officer | Form 4 sale | 4,779 | $142k | 8.0% | Plan not stated | SEC |